Important Announcements

Nondiscrimination Policy Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To read our full Nondiscrimination Statement, click here.

Fabio Petrocca, MD
Profile Image
Fabio Petrocca, MD
Director, Cellular Therapy Program, BMC

(He/Him)

Fabio Petrocca, MD, is an oncologist at Boston Medical Center (BMC), where he is also Director of the CAR T-cell Therapy Program. Dr. Petrocca is also an assistant professor of Medicine and Director of the Cellular Therapy Program at Boston University Chobanian & Avedisian School of Medicine. He is a physician-scientist focused on treating benign and malignant hematologic conditions, including lymphomas, leukemias, and multiple myeloma. His research focuses on the development of immune effector cell therapies for cancer and enabling equitable patient access to innovative and powerful cancer cell therapies such as CAR T. After completing his medical degree and oncology training in Italy, Dr. Petrocca completed a research fellowship at the Program in Cellular and Molecular Medicine at Harvard Medical School. He has been practicing for more than 15 years.

Read more on LinkedIn